Why the study?
Does adiponectin improve left ventricular systolic dysfunction in mice with LPS-induced acute cardiac injury?
Does adiponectin improve left ventricular systolic dysfunction in mice with LPS-induced acute cardiac injury?
Adiponectin protects against endotoxin-induced acute cardiac injury by suppressing inflammatory responses, highlighting a potential therapeutic target for sepsis-associated myocardial dysfunction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for adiponectin in sepsis cardiomyopathy; human studies required before any clinical consideration.
BACKGROUND: Obesity is a risk factor for cardiovascular disease. Increasing evidence suggests that reduced levels of the adipocyte-derived plasma protein adiponectin are associated with an increased cardiovascular risk. Here, we examined the effects of adiponectin on lipopolysaccharide- (LPS-) induced acute cardiac injury in vivo. METHODS AND RESULTS: A single dose of LPS (10 mg/kg) was intraperitoneally injected into wild-type (WT) and adiponectin-knockout (APN-KO) mice. Following LPS administration, APN-KO mice had exacerbation of left ventricular (LV) systolic dysfunction compared with WT mice. Administration of LPS to WT and APN-KO mice led to an increased expression of inflammatory cytokines including TNF-α and IL-6 in the heart, but the magnitude of this induction was greater in APN-KO mice compared to WT mice. Systemic delivery of an adenoviral vector expressing adiponectin (Ad-APN) improved LPS-induced LV dysfunction in APN-KO mice, and this effect was accompanied by the reduced expression of TNF-α and IL-6 in the heart. Administration of etanercept, a soluble TNF receptor abolished the reduced LV contractile function in response to LPS in APN-KO mice. CONCLUSION: These results suggest that adiponectin protects against LPS-induced acute cardiac injury by suppressing cardiac inflammatory responses, and could represent a potential therapeutic target in sepsis-associated myocardial dysfunction.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: